Search Results
Showing results 1 to 20 of 35.
Event
APHA Annual Meeting 2021
October 24, 2021
Article
Mental Health and Substance Abuse Treatment Prescription Drugs: Lessons From a Period of High Spending Growth
January 01, 2007
News Release
Prior Authorization for Common Opioid Use Disorder Medications Associated with More Adverse Health Outcomes, Study Finds
April 20, 2020
Article
Use of quality measures for Medicaid behavioral health services by state agencies: Implications for health care reform
June 01, 2015
Event
The Role of State Behavioral Health Agencies and State Financing in Expanding Access to Medication Assisted Treatment
August 14, 2018
Announcement
Study Finds No Improvement in Addiction Treatment Initiation and Engagement Rates Among Medicaid and Private Health Plans
February 27, 2020
Announcement
Paper Offers Policy Recommendations to Mitigate Behavioral Health Consequences of COVID-19 Financial Crisis
May 27, 2020
Insight
Why Opioid Misuse Policies Must Comprehensively Address Social Determinants of Health to be Effective
February 17, 2020
Insight
Measurement: The Missing Link to Quality Addiction Treatment
August 26, 2019
Impact
SAMHSA’s Performance Accountability and Reporting System (SPARS)
February 21, 2018
News Release
Medicare Part D Plans Have Removed Barriers to Opioid Use Disorder Medications
July 09, 2019
Insight
Can Money Alone Solve the Opioid Epidemic?
July 15, 2019
Expert
Laura J. Dunlap
Expert
Tami Mark
Expert
Sara L. Calvin
Event
Webinar: How to Improve Addiction Treatment by Systematically Tracking Patient Outcomes
February 05, 2019
News Release
New study aims to improve patient retention rates and outcomes in substance abuse treatment
December 14, 2017
News Release
RTI International Develops Quality Measures to Improve Substance Use Disorder Treatment
March 31, 2021
News Release
New Study Finds Patients on High Doses of Opioid Medication Are Being Rapidly Discontinued, Leading to Greater Risk of Emergency Department Visits and Hospitalizations
May 16, 2019
Announcement
Foundation for Opioid Response Efforts (FORE) Announces Grants Totaling $1.3 Million to Assess Impact of COVID-19 on Opioid Use Disorder Treatment and Equity
March 16, 2021